Neuronal Zinc Transporter ZnT3 Modulates Cerebral Ischemia-Induced Blood-Brain Barrier Disruption
Aging and disease · 2023
DOI: 10.14336/ad.2023.1011 ↗Kurz gefasst
Fachartikel in der Zeitschrift Aging and disease, 2023. Verfasst von Zhifeng Qi und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Cerebrovascular Diseases Research Institute, Xuanwu Hospital of Capital Medical University, Beijing, China. Hauptthemen laut MEDLINE: Blood-Brain Barrier, Cation Transport Proteins, Zinc, Brain Ischemia. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Zinc plays important roles in both physiological and pathological processes in the brain. Accumulation of free zinc in ischemic tissue is recognized to contribute to blood-brain barrier (BBB) disruption following cerebral ischemia, but little is known either about the source of free zinc in microvessels or the mechanism by which free zinc mediates ischemia-induced BBB damage. We utilized cellular and animal models of ischemic stroke to determine the source of high levels of free zinc and the mechanism of free zinc-mediated BBB damage after ischemia. We report that cerebral ischemia elevated the level of extracellular fluid (ECF-Zn) of ischemic brain, leading to exacerbated BBB damage in a rat stroke model. Specifically suppressing zinc release from neurons, utilizing neuronal-specific zinc transporter 3 (ZnT3) knockout mice, markedly reduced ECF-Zn and BBB permeability after ischemia. Intriguingly, the activity of zinc-dependent metalloproteinase-2 (MMP-2) was modulated by ECF-Zn levels. Elevated ECF-Zn during ischemia directly bound to MMP-2 in extracellular fluid, increased its zinc content and augmented MMP-2 activity, leading to the degradation of tight junction protein in cerebral microvessels and BBB disruption. These findings suggest the role of neuronal ZnT3 in modulating ischemia-induced BBB disruption and reveal a novel mechanism of MMP-2 activation in BBB disruption after stroke, demonstrating ZnT3 as an effective target for stroke treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Neurology, Cerebrovascular Diseases Research Institute, Xuanwu Hospital of Capital Medical University, Beijing, China.
- Department of Pharmaceutical Sciences, University of New Mexico Health Sciences Center, Albuquerque, NM 87131, USA.
- Department of Pathology, Stony Brook University, Stony Brook, NY 11794, USA.
Zitieren
APA
Qi, Z., Zhou, X., Dong, W., Timmins, G. S., Pan, R., Shi, W., Yuan, S., Zhao, Y., Ji, X., & Liu, K. J. (2023). Neuronal Zinc Transporter ZnT3 Modulates Cerebral Ischemia-Induced Blood-Brain Barrier Disruption. Aging and disease. https://doi.org/10.14336/ad.2023.1011
Vancouver
Qi Z, Zhou X, Dong W, Timmins GS, Pan R, Shi W, et al. Neuronal Zinc Transporter ZnT3 Modulates Cerebral Ischemia-Induced Blood-Brain Barrier Disruption. Aging and disease. 2023. doi:10.14336/ad.2023.1011
BibTeX
@article{Qi2023,
author = {Qi, Zhifeng and Zhou, Xixi and Dong, Wen and Timmins, Graham S and Pan, Rong and Shi, Wenjuan and Yuan, Shuhua and Zhao, Yongmei and Ji, Xunming and Liu, Ke Jian},
title = {Neuronal Zinc Transporter ZnT3 Modulates Cerebral Ischemia-Induced Blood-Brain Barrier Disruption},
journal = {Aging and disease},
year = {2023},
doi = {10.14336/ad.2023.1011}
}
EUVIMED